On this page
Quality management
Laboratory Director Li Jianming leads quality control and quality assurance across the stages of embryo culture.
Genetic testing within treatment
Preimplantation genetic testing uses embryo biopsy samples to investigate the planned genetic question. INCITA offers PGT-A, PGT-M and PGT-SR. Discuss the relevant approach and reporting scope with the team.
Immature eggs and in vitro maturation
Egg maturity is reviewed after retrieval. For patients with low egg maturity or an egg maturation disorder, the laboratory may use in vitro maturation (IVM), in which immature eggs are cultured in specialized medium before ICSI.
The laboratory selects handling according to the development of the retrieved eggs. This work is led by a team with experience in IVM, embryo micromanipulation and individualized culture approaches.
Laboratory quality control
Li Jianming’s laboratory leadership includes systematic quality control and quality assurance through the stages of in vitro embryo culture. He holds the HCLD qualification and has served as a CAP inspector.
These are professional qualifications held by the laboratory director. They should be distinguished from accreditation of a hospital or of a particular testing laboratory.
Laboratory work within a treatment cycle
| Stage | Laboratory work |
|---|---|
| After retrieval | Assessment and preparation of eggs and sperm |
| Fertilization | Conventional IVF or ICSI according to the plan |
| Development | Embryo culture and blastocyst assessment |
| Genetic testing | Embryo biopsy and coordination of the planned genetic analysis |
| Preservation | Egg, sperm or embryo freezing and subsequent warming |
Experience across the team
The embryology team includes experience in centers in mainland China, Hong Kong, Macau and the United States. Individual team members contribute skills in andrology, embryo culture, biopsy, PCR methods, cryopreservation and laboratory quality control.
Clinical and laboratory findings are reviewed together, particularly when patients arrive with previous poor egg maturity, poor blastocyst development or unsuccessful treatment elsewhere.